Literature DB >> 10497235

Identification of triadin 1 as the predominant triadin isoform expressed in mammalian myocardium.

Y M Kobayashi1, L R Jones.   

Abstract

Triadin is an integral membrane protein of sarcoplasmic reticulum shown to interact with the ryanodine receptor/Ca(2+) release channel, junctin, and calsequestrin. Several triadin isoforms have been postulated to exist in cardiac muscle, but to date none has been conclusively identified. Here, we show that only triadin 1 is significantly expressed. We cloned and sequenced cDNAs encoding canine cardiac triadin 1 and 3 but found no evidence for triadin 2. From deduced primary structures, antibodies against domains common to all triadins and an antibody against the unique C terminus of triadin 1 were raised. All antibodies detected two prominent proteins of molecular masses 35 and 40 kDa on immunoblots from cardiac microsomes, including the antibody that recognizes only triadin 1. The 40-kDa mobility form was shown to correspond to the glycosylated form of triadin 1, not a distinct triadin 2 isoform as previously hypothesized. Confirming this, overexpression of triadin 1 in transgenic mouse hearts produced both the 35-kDa deglycosylated and the 40-kDa glycosylated mobility forms. The glycosylation site of triadin 1 was localized to asparagine residue 75, and its bitopic arrangement in the membrane was confirmed. Although a 92-kDa immunoreactive protein could be tentatively identified in myocardium as triadin 3, its expression level was insignificant (</=5%) compared with that of triadin 1. We conclude that triadin 1 is the triadin isoform most likely to play a role in Ca(2+) release in heart.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10497235     DOI: 10.1074/jbc.274.40.28660

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

1.  The role of calsequestrin, triadin, and junctin in conferring cardiac ryanodine receptor responsiveness to luminal calcium.

Authors:  Inna Györke; Nichole Hester; Larry R Jones; Sandor Györke
Journal:  Biophys J       Date:  2004-04       Impact factor: 4.033

2.  Triadins are not triad-specific proteins: two new skeletal muscle triadins possibly involved in the architecture of sarcoplasmic reticulum.

Authors:  Stéphane Vassilopoulos; Dominique Thevenon; Sophia Smida Rezgui; Julie Brocard; Agnès Chapel; Alain Lacampagne; Joël Lunardi; Michel Dewaard; Isabelle Marty
Journal:  J Biol Chem       Date:  2005-05-31       Impact factor: 5.157

3.  Phosphorylation and dephosphorylation of calsequestrin on CK2-sensitive sites in heart.

Authors:  Michal L Ram; Arash Kiarash; James D Marsh; Steven E Cala
Journal:  Mol Cell Biochem       Date:  2004-11       Impact factor: 3.396

4.  Trisk 32 regulates IP(3) receptors in rat skeletal myoblasts.

Authors:  Tamás Oláh; János Fodor; Sarah Oddoux; Olga Ruzsnavszky; Isabelle Marty; László Csernoch
Journal:  Pflugers Arch       Date:  2011-08-03       Impact factor: 3.657

5.  Transitions of protein traffic from cardiac ER to junctional SR.

Authors:  Naama H Sleiman; Timothy P McFarland; Larry R Jones; Steven E Cala
Journal:  J Mol Cell Cardiol       Date:  2015-01-29       Impact factor: 5.000

Review 6.  Triadin, not essential, but useful.

Authors:  Paul D Allen
Journal:  J Physiol       Date:  2009-07-01       Impact factor: 5.182

7.  On the footsteps of Triadin and its role in skeletal muscle.

Authors:  Claudio F Perez
Journal:  World J Biol Chem       Date:  2011-08-26

Review 8.  Calsequestrin mutations and catecholaminergic polymorphic ventricular tachycardia.

Authors:  Michela Faggioni; Dmytro O Kryshtal; Björn C Knollmann
Journal:  Pediatr Cardiol       Date:  2012-03-16       Impact factor: 1.655

9.  hnRNP U protein is required for normal pre-mRNA splicing and postnatal heart development and function.

Authors:  Junqiang Ye; Nadine Beetz; Sean O'Keeffe; Juan Carlos Tapia; Lindsey Macpherson; Weisheng V Chen; Rhonda Bassel-Duby; Eric N Olson; Tom Maniatis
Journal:  Proc Natl Acad Sci U S A       Date:  2015-05-26       Impact factor: 11.205

Review 10.  Dysregulated sarcoplasmic reticulum calcium release: potential pharmacological target in cardiac disease.

Authors:  Sandor Györke; Cynthia Carnes
Journal:  Pharmacol Ther       Date:  2008-07-12       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.